MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Historical Holders from Q1 2014 to Q4 2025

Type / Class: Equity / COMMON STOCK
Symbol: MOH on NYSE
Shares outstanding: 53,991,938
Price per share: $173.54
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 56,232,696
Total reported value: $10,758,761,896
% of total 13F portfolios: 0.01%
Share change: +3,022,622
Value change: +$329,733,291
Avg buy value change: +0.01%
Avg sell value change: -0%
Number of holders: 612
Price from insider filings: $173.54

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
PRICE T ROWE ASSOCIATES INC /MD/	6.5%	+60%	$671,573,327	+$249,218,079	3,509,476	+59%	T. Rowe Price Associates, Inc.	30 Sep 2025
AQR CAPITAL MANAGEMENT LLC	5.4%		$561,475,117		2,934,130		AQR Capital Management, LLC	30 Sep 2025
Capital Research Global Investors	4%		$362,798,917		2,166,093		Capital Research Global Investors	30 Jun 2025

As of 30 Sep 2025, MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH) has 612 institutional shareholders filing 13F forms. They hold 56,232,696 shares. .

Top 25 institutional shareholders own 81% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	12%	6,436,745	+0.05%	0.02%	$1,231,735,522
Capital World Investors	9.6%	5,167,169	-2%	0.14%	$988,790,426
BlackRock, Inc.	8.4%	4,552,764	-3.9%	0.02%	$871,216,896
PRICE T ROWE ASSOCIATES INC /MD/	6.5%	3,503,675	+59%	0.07%	$670,464,000
AQR CAPITAL MANAGEMENT LLC	5.4%	2,934,130	+217%	0.36%	$561,475,083
HARRIS ASSOCIATES L P	5%	2,682,141	+74%	0.82%	$513,254,502
STATE STREET CORP	4.5%	2,413,252	-1.9%	0.02%	$461,799,903
FMR LLC	4%	2,154,086	-14%	0.02%	$412,205,832
T. Rowe Price Investment Management, Inc.	3.6%	1,969,661	+31%	0.23%	$376,915,000
GEODE CAPITAL MANAGEMENT, LLC	2.9%	1,556,761	+2.9%	0.02%	$296,809,625
Invesco Ltd.	2.5%	1,361,302	-15%	0.04%	$260,498,752
WELLINGTON MANAGEMENT GROUP LLP	2%	1,064,488	-49%	0.04%	$203,700,423
MORGAN STANLEY	1.8%	984,624	+64%	0.01%	$188,418,031
VICTORY CAPITAL MANAGEMENT INC	1.8%	963,526	+344%	0.12%	$184,380,336
DIMENSIONAL FUND ADVISORS LP	1.7%	938,677	+31%	0.04%	$179,632,362
Capital Research Global Investors	1.5%	792,786	-63%	0.03%	$151,707,529
GOLDMAN SACHS GROUP INC	1.1%	611,169	+94%	0.02%	$116,953,390
UBS Group AG	1.1%	603,934	+321%	0.02%	$115,568,810
NORTHERN TRUST CORP	1.1%	569,023	+4.9%	0.01%	$108,888,242
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.99%	535,450	+28%	0.02%	$102,463,712
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC	0.82%	443,254	-21%	0.02%	$84,821,085
JACOBS LEVY EQUITY MANAGEMENT, INC	0.69%	369,980	-14%	0.28%	$70,799,373
Legal & General Group Plc	0.65%	350,231	+10%	0.02%	$67,020,200
RENAISSANCE TECHNOLOGIES LLC	0.59%	320,237	-29%	0.08%	$61,280,552
DEUTSCHE BANK AG\	0.59%	317,995	+4.8%	0.02%	$60,851,524

Institutional Holders of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	376,883	$65,451,395	+$36,262,908			17,354%	15
2025 Q3	56,232,696	$10,758,761,896	+$329,733,291	$112,710,021	$144,039,794	19,136%	612
2025 Q2	53,143,940	$15,814,935,347	-$59,530,411	$31,873,684	$28,834,807	29,790%	619
2025 Q1	53,243,308	$17,531,431,564	+$90,257,516	$42,289,912	$54,546,718	32,939%	610
2024 Q4	53,120,899	$15,460,353,918	-$720,310,499	$84,913,192	$62,302,242	29,105%	622
2024 Q3	55,222,233	$19,016,902,906	-$1,098,721,238	$105,027,724	$93,051,886	34,456%	605
2024 Q2	58,645,629	$17,434,127,004	+$701,052,046	$61,310,395	$55,327,530	29,730%	624
2024 Q1	56,217,112	$23,080,576,488	-$646,241,660	$47,204,367	$37,385,530	41,083%	617
2023 Q4	444,048	$160,386,624	-$4,551,646			36,131%	9
2023 Q3	57,100,121	$18,726,857,201	-$10,572,401	$66,791,193	$52,495,189	32,789%	548
2023 Q2	56,154,496	$16,901,501,115	+$237,648,725	$56,332,135	$83,413,356	30,124%	536
2023 Q1	56,520,544	$15,122,378,264	+$30,825,612	$96,608,970	$82,503,327	26,749%	539
2022 Q4	56,219,938	$18,550,249,915	+$152,812,743	$118,548,856	$43,819,774	33,022%	572
2022 Q3	55,580,027	$18,336,897,065	-$614,174,086	$85,430,000	$41,365,000	32,984.02%	540
2022 Q2	54,585,802	$15,179,713,122	-$235,465,807	$36,841,364	$29,880,244	27,961.01%	514
2022 Q1	56,159,416	$18,731,631,977	+$569,059,475	$30,839,000	$31,731,000	33,358.91%	511
2021 Q4	54,269,179	$17,247,420,159	-$284,367,846	$29,807,000	$20,402,000	31,807.93%	480
2021 Q3	55,297,819	$15,005,331,446	+$44,771,732	$27,700,588	$15,900,000	27,131.01%	428
2021 Q2	55,151,619	$13,959,313,386	-$38,765,071	$40,916,000	$13,386,000	25,305.93%	431
2021 Q1	55,435,261	$12,952,774,585	+$28,855,392	$49,295,000	$18,966,000	23,376%	423
2020 Q4	54,600,723	$11,608,898,173	-$356,928,688	$33,603,000	$11,633,000	21,268%	396
2020 Q3	54,054,216	$9,884,828,045	-$34,401,349	$96,507,000	$33,328,000	18,303.94%	386
2020 Q2	55,264,772	$9,832,167,056	-$148,286,523	$76,539,000	$30,044,000	17,797.75%	376
2020 Q1	56,085,563	$7,833,558,541	-$481,888,566	$48,502,000	$29,223,000	13,971.08%	296
2019 Q4	63,999,285	$8,683,296,128	+$494,951,189	$63,888,000	$61,607,000	13,568.9%	309
2019 Q3	60,405,443	$6,625,629,502	-$54,054,166	$47,379,000	$111,304,000	10,971.99%	313
2019 Q2	60,813,812	$8,699,214,999	-$121,234,086	$70,396,000	$215,885,000	14,313.92%	345
2019 Q1	62,737,722	$8,905,217,844	-$375,964,347	$66,779,000	$47,825,000	14,195.95%	340
2018 Q4	65,476,686	$7,609,306,666	-$125,561,394	$30,823,000	$13,446,000	11,621.93%	321
2018 Q3	66,347,901	$9,863,204,740	-$586,935,966	$51,075,000	$20,059,000	14,870%	328
2018 Q2	71,821,016	$7,035,018,177	+$176,872,724	$15,187,000	$27,668,000	9,794%	277
2018 Q1	70,535,158	$5,726,177,093	+$630,427,725	$11,258,000	$4,376,000	8,117.93%	240
2017 Q4	61,696,743	$4,731,534,104	+$213,868,336	$10,617,000	$26,440,000	7,668%	252
2017 Q3	60,280,968	$4,128,395,264	+$330,006,250	$34,036,000	$76,498,000	6,875.94%	221
2017 Q2	54,693,129	$3,783,897,540	+$183,715,774	$2,849,000	$7,349,000	6,918%	249
2017 Q1	53,342,187	$2,432,626,099	+$214,808,755	$5,596,000	$5,159,000	4,560%	234
2016 Q4	52,084,723	$2,825,666,010	+$39,267,586	$3,386,000	$2,679,000	5,425.99%	266
2016 Q3	50,476,994	$2,941,876,451	+$96,454,552	$2,767,000	$5,638,000	5,831.96%	266
2016 Q2	48,931,359	$2,442,161,289	+$35,700,940	$18,044,000	$36,392,000	4,990%	254
2016 Q1	47,140,571	$3,039,806,444	-$106,530,898	$684,000	$3,172,000	6,448.99%	270
2015 Q4	51,029,853	$3,067,717,154	+$134,099,227	$4,666,000	$2,357,000	6,013.01%	278
2015 Q3	48,642,284	$3,348,816,154	+$82,346,126	$5,114,000	$13,807,000	6,884.96%	292
2015 Q2	47,049,861	$3,298,381,324	+$443,596,335	$10,799,000	$6,258,000	7,030%	264
2015 Q1	40,605,796	$2,732,071,094	+$157,894,023	$27,000	$1,479,000	6,728.91%	227
2014 Q4	38,477,028	$2,059,578,791	+$82,014,799	$0	$132,000	5,353%	193
2014 Q3	36,882,532	$1,560,118,286	+$30,455,803	$523,000	$7,888,000	4,230%	183
2014 Q2	36,743,879	$1,639,435,055	+$105,051,781	$1,557,000	$9,903,000	4,463.01%	185
2014 Q1	34,428,233	$1,292,897,424	+$11,575,278	$466,000	$8,944,000	3,756.01%	169